Ischemic stroke
Conditions
Interventions
edarafen dextrocanol:Treating with edarafen dextrocanol
Sponsors
The First Hospital of Shanxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 120 Years
Inclusion criteria
Inclusion criteria: 1. Age was 18 years old; 2. Clinical diagnosis of acute ischemic stroke; 3. Have received the informed consent content and agreed to participate; 4. The stroke occurred from 72 hours to admission.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1. Patients during pregnancy or lactation or planned pregnancy within 90 days; 2. Patients with severe renal failure (eGFR <30 ml/min); 3. Patients with severe mental disorder or unable to complete informed consent and follow-up due to dementia; 4. Complicated malignancy or severe systemic disease with an expected survival of less than 90 days; 5. Have participated in other clinical intervention studies within 30 days before registration or are participating in other clinical intervention investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients with mRS between 0 to 1 ; | — |
Countries
China
Contacts
Public ContactXiaoyuan Niu
First Hospital of Shanxi Medical University
Outcome results
None listed